SCHEMBL20819540

SCHEMBL20819540

COc1cc(C)c(Br)cc1C1(C(=O)O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.40
▸ LCK P06239 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ LPAR1 Q92633 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SELL P14151 1/20 0.34
▸ SELP P16109 1/20 0.34
▸ CA12 O43570 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20819738 0.87 RXRA (0.36) MAPTLPAR1SELLSELPCA12
SCHEMBL20819534 0.86 KDM4E (0.39) MAPTLPAR1MEN1KMT2AL3MBTL1
SCHEMBL20819566 0.83 PTGS2 (0.37) TSHRALDH1A1RAB9ALPAR1CA12
SCHEMBL20819569 0.82 CA1 (0.43) LCKFYNSMN1; SMN2CA12CA1
SCHEMBL20819614 0.81 MEN1 (0.36) TSHRSMN1; SMN2ALDH1A1MAPTNPC1
SCHEMBL20819559 0.78 SELP (0.34) LPAR1SELLSELPMEN1KMT2A
SCHEMBL20789974 0.78 ACHE (0.44) TSHRALDH1A1MAPTLPAR1MEN1
SCHEMBL4711456 0.78 LPAR1 (0.46) SMN1; SMN2ALDH1A1MAPTLPAR1MEN1
SCHEMBL20819564 0.77 RXRA (0.34) LPAR1MEN1KMT2AL3MBTL1LMNA
SCHEMBL20819542 0.77 L3MBTL1 (0.33) MAPTLPAR1SELLSELPMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681864-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie Overseas S.à r.l. (LU) 2020-07-22 — — EP disclosed
WO-2019053634-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie S.à.r.l. (LU) 2019-03-21 — — WO disclosed
Send feedback